Ann: ResApp announces positive results of COVID-19 screening test, page-294

First 294 Last

Share
Profile

Follow
Sonny87

46 Posts.

137

23/03/22

11:22

Post #: 60363448
Share
Originally posted by ashtool: ↑

How is the app going to work for the very many (in some age brackets, the majority) who are asymptomatic and have no cough? It won't, thus people will still need RATs and PCRs.
How can an 80% clinical specificity (ie: 1/5 who are true 'positive' get a false-negative and re-enter the community) be reliable at all? I would be surprised if this underwhelming result even passes the TGA standard when it comes to it.
How does RAP substantiate its claim of "92% sensitivity for detecting COVID-19 with a new cough audio-based algorithm –exceeding the real-world measured sensitivity of rapid antigen testing" when the majority of new RATs being approved by the TGA have > 95% clinical sensitivity and > 98% clinical specificity?

Source: https://www.tga.gov.au/covid-19-rapid-antigen-self-tests-are-approved-australia

Table showing latest TGA approved RATs in Australia for home-use:

Clinical data or product:
This is just one example. Click on any of the "Very High sensitivity" TGA approved products, and all of them leave RAP's results for dead.

These are important questions to ask, given a CR likely approaching.

Expand

Hi Ashtool. Great to see you've heard the news. If you are genuinely interested in understanding the results and their real world application please watch the investor conference call. Their is a great explanation by Professor Catherine Bennett, Deakin’s Chair in Epidemiology within Deakin’s Institute for Health Transformation and member of Resapp's COVID-19 Scientific Advisory Board.
RAP Price at posting: 7.8¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

RCE

Recce's R327 found effective against E.coli during clinical trial

3DP

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring